CompoAtlas

VG3 OMEGA

Food supplement declared in France, declaration No 2017-4-203

VG3 OMEGA (SYNAPSYA) is a food supplement declared in France. Status: retiré du marché le 28 February 2022. 1 rule of use applies to its ingredients (limits and warnings).

Brand
SYNAPSYA
Food business operator placing the product on the market
Laboratoire Synapsya
Status
Retiré du marché le 28 February 2022
Form
Gélule
Daily dose
1 gélule
Directions for use
1 gélule le matin
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Antécédent de cancer du sein, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims)
Mémoire, Sommeil, Œil / Vision

Declaration 162495, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Odontella aurita (Lyngbye) C.AgardhThallePoudre (de plantes séchées ou broyées)110 mg
Linum usitatissimum L.GraineExtrait sec aqueux40 mg

Other active ingredients

NamePer day
Huile de Schizochytrium spnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Acétate de D-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E470b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

VG3 Omega est déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein et chez les enfants de moins de 15 ans.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : SYNAPSYA

Enter to analyse, Shift+Enter for a new line